INS and type 2 diabetes mellitus: While an evening administration is commonly employed, a 2015 study by Porcellati et al directly compared the PK and PD of insulin glargine after evening vs morning subcutaneous injection in individuals with T2DM (220), showing that the pharmacodynamic profile of insulin glargine differed based on the timing of administration.